Prostate Cancer Clinical Trial
Multi-Institutional Registry for Prostate Cancer Radiosurgery
Summary
To address pertinent questions regarding the utilization of stereotactic Body Radiotherapy (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT. The registry is designed to track surrogate treatment endpoints including prostate specific antigen (PSA), international prostate symptom score (IPSS),sexual health in men (SHIM), and visual analogue scale (VAS) scores, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries, FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data, requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.
Full Description
To address pertinent questions regarding the utilization of radiosurgery (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT.
The registry is designed to track surrogate treatment endpoints including PSA, IPSS, SHIM, QOL, Karnofsky Performance Status, VAS scores, urine and bowel health, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries.
FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.
Eligibility Criteria
Inclusion Criteria:
pathological diagnosis of prostate cancer
early or intermediate risk
Exclusion Criteria:
high risk prostate cancer
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 44 Locations for this study
Birmingham Alabama, 35209, United States More Info
Principal Investigator
Mobile Alabama, 36688, United States More Info
Principal Investigator
Phoenix Arizona, 85028, United States More Info
Principal Investigator
Fresno California, 93720, United States More Info
Principal Investigator
Newport Beach California, 92660, United States More Info
Principal Investigator
San Diego California, 92121, United States More Info
Principal Investigator
Tustin California, 92780, United States More Info
Principal Investigator
Colorado Springs Colorado, 80907, United States More Info
Principal Investigator
Lafayette Colorado, 80026, United States More Info
Principal Investigator
Lone Tree Colorado, 80124, United States More Info
Principal Investigator
Washington District of Columbia, 20007, United States More Info
Principal Investigator
Miami Florida, 33156, United States More Info
Principal Investigator
Naples Florida, 34119, United States More Info
Principal Investigator
Pembroke Pines Florida, 33028, United States More Info
Principal Investigator
Stuart Florida, 33996, United States More Info
Principal Investigator
Tampa Florida, 33615, United States More Info
Principal Investigator
Marietta Georgia, 30060, United States More Info
Contact
Principal Investigator
Elmhurst Illinois, 60126, United States More Info
Principal Investigator
Park Ridge Illinois, 60068, United States More Info
Principal Investigator
Lexington Kentucky, 40503, United States More Info
Principal Investigator
Billings Montana, 59102, United States More Info
Principal Investigator
Great Falls Montana, 59504, United States More Info
Principal Investigator
Missoula Montana, 59802, United States More Info
Principal Investigator
Lincoln Nebraska, 68510, United States More Info
Principal Investigator
Henderson Nevada, 89052, United States More Info
Principal Investigator
Red Bank New Jersey, 07701, United States More Info
Principal Investigator
Johnson City New York, 13790, United States More Info
Principal Investigator
Kettering Ohio, 45420, United States More Info
Tulsa Oklahoma, 74104, United States More Info
Principal Investigator
Tulsa Oklahoma, 74132, United States More Info
Tulsa Oklahoma, 74133, United States More Info
Principal Investigator
Havertown Pennsylvania, 19083, United States More Info
Principal Investigator
Nashville Tennessee, 37203, United States More Info
Principal Investigator
Austin Texas, 78701, United States More Info
Principal Investigator
Dallas Texas, 75231, United States More Info
Principal Investigator
Fort Worth Texas, 76104, United States More Info
Contact
Principal Investigator
Houston Texas, 77030, United States More Info
Principal Investigator
San Antonio Texas, 78229, United States More Info
Principal Investigator
Tyler Texas, 75701, United States More Info
Principal Investigator
Falls Church Virginia, 22042, United States More Info
Principal Investigator
Spokane Valley Washington, 99216, United States More Info
Contact
Principal Investigator
Vancouver Washington, 98664, United States More Info
Principal Investigator
Huntington West Virginia, 25702, United States More Info
Principal Investigator
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.